Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease.

导出 LinkOut

翻译打印收藏纠错

作者： Francesco,Ferrau ^[1] ; Francesco,Trimarchi ; Salvatore,Cannavo

作者单位： Department of Clinical and Experimental Medicine, University of Messina, AOU Policlinico "G. Martino" (Pad. H, 4th Floor), Via Consolare Valeria 1, 98125, Messina, Italy, francesco.ferrau1@gmail.com. ^[1]

主题词促肾上腺皮质激素(Adrenocorticotropic Hormone);减量调节(Down-Regulation);女(雌)性(Female);激素拮抗药(Hormone Antagonists);人类(Humans);男(雄)性(Male);中年人(Middle Aged);米非司酮(Mifepristone);奥曲肽(Octreotide);垂体ACTH分泌过多(Pituitary ACTH Hypersecretion)

DOI 10.1007/s12020-013-0163-0

PMID 24408052

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览131

Endocrine

2014年47卷2期

550-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease.

Endocrine

相似文献

Endocrine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease.

Endocrine

相似文献

Endocrine

相关期刊

检索历史清除